quinazolines has been researched along with Bronchial Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berezo, JÁ; de la Cruz, V; Sanz Rubiales, A; Torres, MÁ | 1 |
| Bottke, H; Günthner, W | 1 |
1 trial(s) available for quinazolines and Bronchial Diseases
| Article | Year |
|---|---|
[On the treatment of bronchial asthma with antihistaminics. Clinical and experimental results with 1-dimethylaminoethyl-2-alpha-pyridyl-4-oxo-1,2,3,4-tetrahydroquinazoline].
Topics: Asthma; Bronchial Diseases; Bronchial Spasm; Clinical Trials as Topic; Histamine H1 Antagonists; Humans; Placebos; Quinazolines; Spirometry | 1966 |
1 other study(ies) available for quinazolines and Bronchial Diseases
| Article | Year |
|---|---|
Erlotinib or gefitinib as first-choice therapy for bronchorrhea in bronchioloalveolar carcinoma.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Aged; Bronchi; Bronchial Diseases; Erlotinib Hydrochloride; Gefitinib; Humans; Lung Neoplasms; Male; Quinazolines; Radiography, Thoracic | 2014 |